KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Other Accumulated Expenses (2021 - 2023)

Teladoc Health's Other Accumulated Expenses history spans 3 years, with the latest figure at $33.5 million for Q1 2023.

  • On a quarterly basis, Other Accumulated Expenses changed N/A to $33.5 million in Q1 2023 year-over-year; TTM through Mar 2023 was $33.5 million, a N/A change, with the full-year FY2022 number at $49.9 million, up 85.32% from a year prior.
  • Other Accumulated Expenses hit $33.5 million in Q1 2023 for Teladoc Health, down from $49.9 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for TDOC hit a ceiling of $49.9 million in Q4 2022 and a floor of $8.6 million in Q3 2022.
  • Historically, Other Accumulated Expenses has averaged $29.7 million across 3 years, with a median of $30.2 million in 2021.
  • The widest YoY moves for Other Accumulated Expenses: up 85.32% in 2022, down 85.32% in 2022.
  • Tracing TDOC's Other Accumulated Expenses over 3 years: stood at $27.0 million in 2021, then surged by 85.32% to $49.9 million in 2022, then tumbled by 32.94% to $33.5 million in 2023.
  • Business Quant data shows Other Accumulated Expenses for TDOC at $33.5 million in Q1 2023, $49.9 million in Q4 2022, and $8.6 million in Q3 2022.